The Current Ratio as of December 2024 (TTM) for Abeona Therapeutics Inc. (ABEO) is 6.12

According to Abeona Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.12. This represents a change of 4.74% compared to the average of 5.84 of the last 4 quarters.

Abeona Therapeutics Inc. (ABEO) Historical Current Ratio (quarterly & annually)

How has ABEO Current Ratio performed in the past?

The mean historical Current Ratio of Abeona Therapeutics Inc. over the last ten years is 8.94. The current 6.12 Current Ratio has changed 6.74% with respect to the historical average. Over the past ten years (40 quarters), ABEO's Current Ratio was at its highest in in the September 2015 quarter at 27.83. The Current Ratio was at its lowest in in the June 2021 quarter at 1.88.

Abeona Therapeutics Inc. (ABEO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Abeona Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Abeona Therapeutics Inc. (ABEO) Average Current Ratio

How has ABEO Current Ratio performed in the past?

The current Current Ratio of Abeona Therapeutics Inc. (ABEO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Abeona Therapeutics Inc. (ABEO) Current Ratio vs. Peers

How is ABEO’s Current Ratio compared to its peers?

Abeona Therapeutics Inc.’s Current Ratio is greater than Reviva Pharmaceuticals Holdings, Inc. (0.39), greater than Athira Pharma, Inc. (2.95), greater than Fortress Biotech, Inc. (1.23), greater than ACADIA Pharmaceuticals Inc. (2.29), less than Cabaletta Bio, Inc. (8.11), less than Calithera Biosciences, Inc. (0), greater than Affimed N.V. (3.60), greater than Checkpoint Therapeutics, Inc. (1.93), greater than Adaptimmune Therapeutics plc (0.29), greater than Mereo BioPharma Group plc (3.85), greater than Pieris Pharmaceuticals, Inc. (6.10), greater than PDS Biotechnology Corporation (4.82), greater than Leap Therapeutics, Inc. (2.84), greater than X4 Pharmaceuticals, Inc. (3.97), greater than Terns Pharmaceuticals, Inc. (4.89), less than Day One Biopharmaceuticals, Inc. (32.99), less than Inozyme Pharma, Inc. (14.62), less than REGENXBIO Inc. (7.68), greater than Anebulo Pharmaceuticals, Inc. (3.05), greater than Invivyd, Inc. (3.45), greater than Black Diamond Therapeutics, Inc. (1.92), greater than null (5.55),

Build a custom stock screener for Abeona Therapeutics Inc. (ABEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abeona Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abeona Therapeutics Inc. (ABEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abeona Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.